EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic Mechanisms of Integrase Strand Transfer Inhibitor-Associated Weight Gain: A Multiomics Study in Male People With HIV

Xin Huang, Ziyan Wang, Yixuan Wang, Xiaojing Song, Leidan Zhang, Liyuan Zheng, Fada Wang, Taisheng Li iD, Wei Cao iD

The Journal of Infectious Diseases · 27.07.2026

DOI: 10.1093/infdis/jiag385 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 27.07.2026. Verfasst von Xin Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing…. Hauptthemen laut MEDLINE: HIV Infections, HIV Integrase Inhibitors, Weight Gain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prevention and Control of Emerging, Major Infectious Diseases-National Science and Technology Major Project, Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Integrase strand transfer inhibitors (INSTI) are recommended as first-line antiretroviral therapy for human immunodeficiency virus (HIV) infection, yet are frequently associated with excessive weight gain.

Methods

We conducted a multiomics study on male people with HIV (PWH). A total of 64 male PWH were enrolled and stratified based on their therapeutic history and weight changes over the first year (G1 receiving INSTI with weight gain ≥ 5%; G2 switching to INSTI with weight gain ≥ 5%; and G3 switching to INSTI without weight gain). Integrase strand transfer inhibitor-based regimens included bictegravir-, elvitegravir-, and dolutegravir-containing combinations. Twenty-six healthy male controls were also included. Plasma untargeted metabolomics and proteomics were analyzed longitudinally. Machine learning models were employed to integrate multiomics data and identify predictive biomarkers.

Results

Metabolomic analysis revealed that switching to INSTI induced a generalized hypometabolic state, characterized by a universal decline in thyroxine and an increase in N-acetylputrescine across all switching groups, independent of weight outcomes. In contrast, proteomic profiling identified distinct molecular drivers specific to the weight-gain groups. Random forest modeling identified transthyretin (TTR) as the top predictive biomarker among pre-INSTI multiomics features.

Conclusions

Our integrated multiomics approach reveals that INSTI-based regimens induce universal metabolic changes. The change of thyroxine and the predictability of TTR in multiomics studies show the critical role of thyroxine metabolism in INSTI-associated weight gain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV Integrase InhibitorsWeight GainHumansMaleMultiomicsAdultPyridonesPiperazinesMetabolomicsMiddle AgedQuinolonesDolutegravirProteomicsHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, 3-RingBiomarkersPyridazinesAmides

Stichwörter der Autor:innen

HIVintegrase strand transfer inhibitors (INSTI)multiomicsthyroxineweight gain

Substanzen

HIV Integrase InhibitorsPyridonesPiperazinesQuinoloneselvitegravirDolutegravirbictegravirHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, 3-RingBiomarkers

Autor:innen und Institutionen

  • Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Center for AIDS Research, Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Taisheng Li, Wei Cao

Förderung

  • Prevention and Control of Emerging
  • Major Infectious Diseases-National Science and Technology Major Project
  • Chinese Academy of Medical Sciences
  • Innovation Fund for Medical Sciences

Zitieren

APA

Huang, X., Wang, Z., Wang, Y., Song, X., Zhang, L., Zheng, L., Wang, F., Li, T., & Cao, W. (2026). Metabolic Mechanisms of Integrase Strand Transfer Inhibitor-Associated Weight Gain: A Multiomics Study in Male People With HIV. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag385

Vancouver

Huang X, Wang Z, Wang Y, Song X, Zhang L, Zheng L, et al. Metabolic Mechanisms of Integrase Strand Transfer Inhibitor-Associated Weight Gain: A Multiomics Study in Male People With HIV. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiag385

BibTeX
@article{Huang2026,
  author = {Huang, Xin and Wang, Ziyan and Wang, Yixuan and Song, Xiaojing and Zhang, Leidan and Zheng, Liyuan and Wang, Fada and Li, Taisheng and Cao, Wei},
  title = {Metabolic Mechanisms of Integrase Strand Transfer Inhibitor-Associated Weight Gain: A Multiomics Study in Male People With HIV},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  doi = {10.1093/infdis/jiag385}
}
Kostenlos starten →